Denosumab for osteoporosis in older adults in long‐term care: A randomized trial
Denosumab was a safe and effective therapy for improving BMD in osteoporotic older men and women with multiple comorbidities in LTC.
Authors
- Neil M. Resnick (ORCID: https://orcid.org/0009-0000-2023-809X)
- David A. Nace (ORCID: https://orcid.org/0000-0002-3742-6991)
- Nami Safai Haeri (ORCID: https://orcid.org/0000-0002-5115-5980)
- Subashan Perera (ORCID: https://orcid.org/0000-0002-5509-8928)
- Susan L. Greenspan
Institutions
- University of Pittsburgh (US)
Publication Details
- Journal
- Journal of the American Geriatrics Society
- Published
- 2024-11-10
- DOI
- https://doi.org/10.1111/jgs.19260
- Citations
- 7
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 3.34
Funders
- National Institute on Aging